Lineage Cell Therapeutics, Inc. Effective Income Tax Rate Reconciliation Gilti Amount
Lineage Cell Therapeutics, Inc. (LCTX) reported Effective Income Tax Rate Reconciliation Gilti Amount of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount · last filed 2024-11-14
- Lineage Cell Therapeutics, Inc. effective income tax rate reconciliation gilti amount for the quarter ending 2024-09-30 was $0.00.
- Lineage Cell Therapeutics, Inc. effective income tax rate reconciliation gilti amount for the quarter ending 2024-06-30 was $0.00.
- Lineage Cell Therapeutics, Inc. effective income tax rate reconciliation gilti amount for the quarter ending 2024-03-31 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation Gilti Amount 3 month | Effective Income Tax Rate Reconciliation Gilti Amount 6 month | Effective Income Tax Rate Reconciliation Gilti Amount 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |